Immusoft
Developer of novel therapies designed for the treatment of rare diseases. The company develops autologous cell therapies based on its immune system programming technology that entails collecting a typ...
Valuation
$65.2M
Latest known
Share Price
N/A
Total Raised
$54.8M
Last Round
N/A